Ataxia-Telangiectasia Mutated and the Mre11-Rad50-NBS1 Complex:Promising Targets for Radiosensitization
スポンサーリンク
概要
- 論文の詳細を見る
Radiotherapy plays a central part in cancer treatment, and use of radiosensitizing agents can greatly enhance this modality. Although studies have shown that several chemotherapeutic agents have the potential to increase the radiosensitivity of tumor cells, investigators have also studied a number of molecularly targeted agents as radiosensitizers in clinical trials based on reasonably promising preclinicaldata. Recent intense research into the DNA damage-signaling pathway revealed that ataxia-telangiectasia mutated (ATM) and the Mre11-Rad50-NBS1 (MRN) complex play central roles in DNA repair and cell cycle checkpoints and that these molecules are promising targets for radiosensitization. Researchers recently developed three ATM inhibitors (KU-55933, CGK733, and CP466722) and an MRN complex inhibitor (mirin) and showed that they have great potential as radiosensitizers of tumors in preclinical studies. Additionally, we showed that a telomerase-dependent oncolytic adenovirus that we developed (OBP-301 [telomelysin]) produces profound radiosensitizing effects by inhibiting the MRN complex via the adenoviral E1B55kDa protein. A recent Phase I trial in the United States determined that telomelysin was safe and well tolerated in humans, and this agent is about to be tested in combinationwith radiotherapy in a clinical trial based on intriguing preclinical data demonstrating that telomelysin and ionizing radiation can potentiate each other. In this review, we highlight the great potential of ATM and MRN complex inhibitors, including telomelysin, as radiosensitizing agents.
論文 | ランダム
- インタビュー 経営学を看護の現場で活かす--餅田敬司氏に聞く (特集 看護現場に経営学的視点を)
- 変わる教育委員会--その活性化策(第88回)教育委員会と首長との関係 必要な支援なければ政策は絵に描いた餅に
- 政治 マニフェストは所詮「絵に描いた餅」--粛々と進む八ツ場ダム建設
- 粟餅販売で過疎集落の希望を生み出す(京都・宮津市) (特集 持続可能な地域づくりと仕事おこし(1))
- カンパニー&ビジネス "公約"も絵に描いた餅、ブルドックソースの十字架